General Hospital of Arta

Arta 47100

0 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, End-stage Renal Disease, Hemodiafiltration, Hemodialysis, Prevention of Thromboembolic Events

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis — Completed